Mackay Shields LLC Novavax Inc Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $2.27 Million - $4.84 Million	-18,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $1.4 Million - $3.97 Million	-12,400 Reduced 39.74%	18,800 $3.41 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $141,732 - $251,100	-1,800 Reduced 5.45%	31,200 $3.48 Million
Q3 2020 Nov 04, 2020	BUY	$79.44 - $178.51 $516,360 - $1.16 Million	6,500 Added 24.53%	33,000 $3.58 Million
Q2 2020 Jul 31, 2020	BUY	$13.86 - $83.61 $367,290 - $2.22 Million	26,500 New	26,500 $2.21 Million

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.